Huashen Zhiyao Technology (Beijing)
Latest round
- Series A
Last raised
- Jun 2022
Total raised
- $75M
Investors
- 5
About Huashen Zhiyao Technology (Beijing)
, trading name as Helixon or Earendil Labs, operates as a pharmaceutical company that focuses on providing AI solutions to protein-based therapeutics. The company's founder Dr. Jian Peng is a professor at Tsinghua University. The company's technology platforms can be categorized into artificial intelligence drug development and high-throughput antibody engineering experiment. The artificial intelligence drug development includes a series of algorithms and application scenarios such as protein structure prediction, protein and antibody function prediction, key region modeling of macromolecular drugs, and protein sequence design. The high-throughput antibody engineering experiment is responsible for flow cytometry analysis, antibody screening, and evaluation of antibody binding activity and neutralization activity. Its Design platform is built for protein design, antibody discovery, protein interface optimization as well as cell engineering. The company generates from development of new drug based on artificial intelligence technology.
Who invested in Huashen Zhiyao Technology (Beijing)
5 investors across 2 rounds
See all investors in Huashen Zhiyao Technology (Beijing)
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Huashen Zhiyao Technology (Beijing)
Who invested in Huashen Zhiyao Technology (Beijing)?
Huashen Zhiyao Technology (Beijing) has 5 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Huashen Zhiyao Technology (Beijing) raised?
Huashen Zhiyao Technology (Beijing) has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Huashen Zhiyao Technology (Beijing) last raise money?
Huashen Zhiyao Technology (Beijing)'s most recent round on record is a Series A, in Jun 2022.
What does Huashen Zhiyao Technology (Beijing) do?
, trading name as Helixon or Earendil Labs, operates as a pharmaceutical company that focuses on providing AI solutions to protein-based therapeutics.
Where is Huashen Zhiyao Technology (Beijing) headquartered?
Huashen Zhiyao Technology (Beijing) is headquartered in Beijing, China.
Which VCs invest in companies like Huashen Zhiyao Technology (Beijing)?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back pharmaceuticals companies at Huashen Zhiyao Technology (Beijing)'s stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series A
Raising like Huashen Zhiyao Technology (Beijing)? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.